abs250.txt	mutations	in	tumor	suppressor	tp53	have	been	inconsistently	linked	to	breastcancer	risk	factors	and	survival		immunohistochemistry	(ihc)	staining	a	primaryclinical	means	of	mutation	determination	only	detects	thatfacilitate	protein	accumulation	(e	g	missense	mutations)	rna-based	pathwaymethods	capture	functional	status	may	aid	understanding	the	role	tp53function	racial	disparities	breast	cancer	was	assessed	amonginvasive	cases	from	carolina	study	(cbcs)(2008-2013)	using	ihc	an	established	signature	(cbcs	thecancer	genome	atlas	(tcga))	frequency	(ihc	rna-based)	wasestimated	association	with	characteristics	pam50	intrinsic	subtype	age	race	relative	differences	(rfds)	95%	confidenceintervals	(95%	ci)	as	measure	approximately	60%	basal-liketumors	were	positive	while	nearly	100%	mutant-like(rna)	luminal	tumors	had	low	positivity	7	9%)	andmutant-like	(rna	1	7%)	mutant-like	(rna)	strongly	associatedwith	â‰¤50	years	high	grade	advanced	stage	disease	large	tumorsize	basal-like	her2	subtypes	black	stronglyassociated	(rfd	24	8%	ci	20	5	29	0)even	after	adjusting	for	11	3%	6	15	0)	associations	attenuated	non-significant	when	measured	by	ihc-basedtp53	is	insensitive	measurement	rna-basedmethods	suggest	prognostic	features	racialdisparities
